标题
Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
作者
关键词
-
出版物
Nature Communications
Volume 7, Issue -, Pages 12878
出版商
Springer Nature
发表日期
2016-09-21
DOI
10.1038/ncomms12878
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
- (2015) Erica Giuliani et al. CURRENT DRUG TARGETS
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
- (2015) Suman Mitra et al. IMMUNITY
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Perforin: structure, function, and role in human immunopathology
- (2015) Ilia Voskoboinik et al. IMMUNOLOGICAL REVIEWS
- Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: Results from Cancer and Leukemia Group B 19808
- (2014) Jonathan E. Kolitz et al. CANCER
- Influence of natural killer cells and perforin-mediated cytolysis on the development of chemically induced lung cancer in A/J mice
- (2014) Manuela Frese-Schaper et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice
- (2014) K. L. Gutbrodt et al. MOLECULAR CANCER THERAPEUTICS
- Chimera of IL-2 Linked to Light Chain of anti-IL-2 mAb Mimics IL-2/anti-IL-2 mAb Complexes Both Structurally and Functionally
- (2013) Jakub Tomala et al. ACS Chemical Biology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
- (2013) Geok Choo Sim et al. JOURNAL OF CLINICAL INVESTIGATION
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma
- (2013) Uday B. Dandamudi et al. JOURNAL OF IMMUNOTHERAPY
- Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy
- (2013) Stephanie Chang et al. OncoImmunology
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Strain-Specific Variation in Murine Natural Killer Gene Complex Contributes to Differences in Immunosurveillance for Urethane-Induced Lung Cancer
- (2012) D. Kreisel et al. CANCER RESEARCH
- Crystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCP
- (2012) E. Lazear et al. JOURNAL OF VIROLOGY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Selectively Expanding Subsets of T Cells in Mice by Injection of Interleukin-2/Antibody Complexes: Implications for Transplantation Tolerance
- (2012) O. Boyman et al. TRANSPLANTATION PROCEEDINGS
- Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
- (2011) Claude Haan et al. CHEMISTRY & BIOLOGY
- Cancer Immunoediting of the NK Group 2D Ligand H60a
- (2011) T. O'Sullivan et al. JOURNAL OF IMMUNOLOGY
- IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor subunit CD25
- (2010) S. Letourneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma
- (2009) Brett H Yamane et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started